This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: The Administrators of the Tulane Educational Fund. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New Orleans, LA (US) (2000 - 2002)
- Boston, MA (US) (2002)
Company Filing History:
Years Active: 2000-2002
Title: Bonny L Dickinson: Innovator in Immunology
Introduction
Bonny L Dickinson is a prominent inventor based in New Orleans, LA (US). She has made significant contributions to the field of immunology, holding a total of 3 patents. Her work focuses on developing non-toxic adjuvants that enhance immune responses, which is crucial for advancing vaccine technology.
Latest Patents
Among her latest patents, Dickinson has developed a mutant enterotoxin effective as a non-toxic oral adjuvant. This invention provides methods and compositions for using a novel mutant form of heat-labile enterotoxin that has lost its toxicity while retaining its immunologic activity. This enterotoxin is utilized in combination with an unrelated antigen to achieve an increased immune response when administered as part of an oral vaccine preparation. Additionally, she has patented a similar mutant enterotoxin effective as a non-toxic adjuvant, further emphasizing her innovative approach to vaccine development.
Career Highlights
Bonny L Dickinson is affiliated with The Administrators of the Tulane Educational Fund, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of immunologic responses and improving vaccine efficacy.
Collaborations
One of her notable collaborators is John D Clements, with whom she has worked closely on various projects related to her patents and research initiatives.
Conclusion
Bonny L Dickinson's contributions to immunology through her innovative patents highlight her role as a leading inventor in the field. Her work not only enhances vaccine technology but also paves the way for future advancements in immunological research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
